Pay more attention on the clinical value of hemoglobin A1c in the management of diabetes care
10.3760/cma.j.issn.1009-9158.2012.06.003
- VernacularTitle:应注重糖化血红蛋白在糖尿病诊疗中的临床价值
- Author:
Donghuan WANG
;
Wenxiang CHEN
- Publication Type:Journal Article
- Keywords:
Hemoglobin A;
glycosylated;
Diabetes mellitus
- From:
Chinese Journal of Laboratory Medicine
2012;35(6):493-496
- CountryChina
- Language:Chinese
-
Abstract:
Diabetes is a worldwide epidemic disease in the twenty-first century.The most danger of diabetes is its complications which are the major cause of morbidity and mortality in diabetic patients.The development and progression of diabetes complications are directly associated with blood glucose levels,Hemoglobin A1c is not only the gold standard for the long-term blood glucose control of diabetic patients,but also the World Health Organization (WHO) recommended diagnosis of diabetes.Thus,a question has been raised:how to improve the comparability of hemoglobin A1c results meet clinical needs? At least four points should be taken in determining hemoglobin A1c:(1)Understand the interference factors; (2)Choose scientific and practical methodologies; (3)Standardized operation; (4)Regularly monitor the quality of testing results.
